BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sonderup MW, Spearman CW. Global Disparities in Hepatitis B Elimination-A Focus on Africa. Viruses 2022;14:82. [PMID: 35062286 DOI: 10.3390/v14010082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Abdo Kampe, Moorthy Kannaiyan Abbai, Dagnamyelew Tilahun, Deresse Daka, Alqeer Aliyo, Wako Dedecha, Alo Edin. Seroprevalence of Hepatitis B Virus Infection and Associated Factors Among Pregnant Women Attending Antenatal Care At Public Hospitals in Borena Zone, Southern Ethiopia. Health Serv Res Manag Epidemiol 2023;10:23333928231161946. [ DOI: 10.1177/23333928231161946] [Reference Citation Analysis]
2 Yendewa GA, James PB, Mohareb AM, Barrie U, Massaquoi SP, Yendewa SA, Ghazzawi M, Bockarie T, Cumming PE, Diallo IS, Johnson A, Vohnm B, Babawo LS, Deen GF, Kabba M, Sahr F, Lakoh S, Salata RA. Childhood Hepatitis B Immunization Coverage and Barriers in Sierra Leone, Liberia, and Guinea: Analysis of National Surveys (2018-2020).. [DOI: 10.1101/2023.03.16.23287374] [Reference Citation Analysis]
3 Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK, Ngeow JYY. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology 2023:S0016-5085(23)00105-1. [PMID: 36738977 DOI: 10.1053/j.gastro.2023.01.033] [Reference Citation Analysis]
4 Makokha GN, Zhang P, Hayes CN, Songok E, Chayama K. The burden of Hepatitis B virus infection in Kenya: A systematic review and meta-analysis. Front Public Health 2023;11:986020. [PMID: 36778557 DOI: 10.3389/fpubh.2023.986020] [Reference Citation Analysis]
5 Nartey YA, Okine R, Seake-Kwawu A, Ghartey G, Asamoah YK, Senya K, Duah A, Owusu-Ofori A, Amugsi J, Suglo D, Bampoh SA, Hiebert L, Njuguna H, Ward JW, Plymoth A, Roberts LR, Bockarie AS, Awuku YA, Obiri-Yeboah D. A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021. BMC Public Health 2022;22:2149. [PMID: 36419017 DOI: 10.1186/s12889-022-14618-3] [Reference Citation Analysis]
6 Kramvis A, Chang KM, Dandri M, Farci P, Glebe D, Hu J, Janssen HLA, Lau DTY, Penicaud C, Pollicino T, Testoni B, Van Bömmel F, Andrisani O, Beumont-Mauviel M, Block TM, Chan HLY, Cloherty GA, Delaney WE, Geretti AM, Gehring A, Jackson K, Lenz O, Maini MK, Miller V, Protzer U, Yang JC, Yuen MF, Zoulim F, Revill PA. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat Rev Gastroenterol Hepatol 2022;19:727-45. [PMID: 35859026 DOI: 10.1038/s41575-022-00649-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 14.0] [Reference Citation Analysis]
7 Pourkarim MR. World Hepatitis Day in 2022: Challenges of Viral Hepatitis Elimination in Elongated COVID-19 Pandemic. Pathogens 2022;11:1002. [DOI: 10.3390/pathogens11091002] [Reference Citation Analysis]
8 Joseph Davey D, Hsiao NY, Wendy Spearman C, Sonderup M, Hu NC, Mashele N, Mvududu R, Myer L. Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out. BMC Infect Dis 2022;22:719. [PMID: 36050648 DOI: 10.1186/s12879-022-07697-5] [Reference Citation Analysis]
9 Maepa MB, Ely A, Kramvis A, Bloom K, Naidoo K, Simani OE, Maponga TG, Arbuthnot P. Hepatitis B Virus Research in South Africa. Viruses 2022;14:1939. [DOI: 10.3390/v14091939] [Reference Citation Analysis]
10 Pourkarim MR. Hepatitis E Virus; An Underestimated Threat for the Viral Hepatitis Elimination Program. Hepat Mon 2022;22. [DOI: 10.5812/hepatmon-129678] [Reference Citation Analysis]
11 Ahmad Bhat S, Islam Siddiqui Z, Ahmad Parray Z, Sultan A, Afroz M, Ali Azam S, Rahman Farooqui S, Naqui Kazim S. Naturally occurring HMGB1 inhibitor delineating the anti-hepatitis B virus mechanism of glycyrrhizin via in vitro and in silico studies. Journal of Molecular Liquids 2022;356:119029. [DOI: 10.1016/j.molliq.2022.119029] [Reference Citation Analysis]
12 Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI, Ali Z, Anderson BO, Anorlu R, Avery S, Barango P, Bih N, Booth CM, Brawley OW, Dangou JM, Denny L, Dent J, Elmore SNC, Elzawawy A, Gashumba D, Geel J, Graef K, Gupta S, Gueye SM, Hammad N, Hessissen L, Ilbawi AM, Kambugu J, Kozlakidis Z, Manga S, Maree L, Mohammed SI, Msadabwe S, Mutebi M, Nakaganda A, Ndlovu N, Ndoh K, Ndumbalo J, Ngoma M, Ngoma T, Ntizimira C, Rebbeck TR, Renner L, Romanoff A, Rubagumya F, Sayed S, Sud S, Simonds H, Sullivan R, Swanson W, Vanderpuye V, Wiafe B, Kerr D. Cancer in sub-Saharan Africa: a Lancet Oncology Commission. Lancet Oncol 2022;23:e251-312. [PMID: 35550267 DOI: 10.1016/S1470-2045(21)00720-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 30.0] [Reference Citation Analysis]
13 Pourkarim M, Nayebzadeh S, Alavian SM, Hataminasab SH. Digital Marketing: A Unique Multidisciplinary Approach towards the Elimination of Viral Hepatitis. Pathogens 2022;11:626. [DOI: 10.3390/pathogens11060626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ssekamatte T, Isunju JB, Nalugya A, Wafula ST, Nuwematsiko R, Doreen N, Kansiime WK, Naume M, Nakiggala J, Bukenya JN, Mugambe RK. Geospatial distribution of Hepatitis B prevention services in Wakiso District, Central Uganda.. [DOI: 10.1101/2022.04.20.22274066] [Reference Citation Analysis]
15 Lee C, Han J, Jung Y. Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease. Biology 2022;11:637. [DOI: 10.3390/biology11050637] [Reference Citation Analysis]